China Holdings, Inc. Announces 2nd Biomass Renewable Energy Project (Power Capacity: 50 MW); Total Potential: 100 MW in Biomass Energ... ( LAS VEGAS Nov. 5 /Xinhua-- China ...)

HOME >> MEDICINE >> NEWS

China Holdings, Inc. Announces 2nd Biomass Renewable Energy Project (Power Capacity: 50 MW); Total Potential: 100 MW in Biomass Energy Pipeline

Date:11/5/2007

LAS VEGAS, Nov. 5 /Xinhua-PRNewswire-FirstCall/ -- China Holdings, Inc. (OTC Bulletin Board: CHHL), a global diversified asset holdings Company, and its subsidiaries engage in multiple China-focused business activities including energy, renewable energy, resources, utilities, finance, real estate, and pharmaceuticals, announced today the Company has executed its 2nd development contract for the exclusive rights to develop and construct the 2nd Biomass Renewable Energy Project (Power Capacity: 50 MW) through its controlled subsidiary "China Power, Inc." with the local government in AnHui Province, the People's Republic of China. The breakthrough brought the Company potential power capacity: 100 MW in a biomass energy pipeline

All resources needed to develop/construct the 2nd 50 MW Biomass Renewable Energy Project such as power supplies, water supplies and straw supplies and 215 MU (1 MU = 667 sq. meters) of land position have been secured. The Company has secured, and/or will have secured the Advanced Technology (CAPS-II pyrolysis system, the leading technologies of biomass energy systems around the world), Efficient Combustion Resulting in Clean Emission (CAPS-II pyrolysis system is environmentally friendly and economically profitable, in disposing agricultural waste), and Modular Design Maximizing Flexibility etc.

The 2nd Biomass Energy Project (Power Capacity: 50MW) has very similar advantages and benefits from government polices and design as the Company's 1st Biomass Energy Project. The 2nd Biomass Energy Project (50 MW) has the total expected annual power generating capacity of 400 million kilowatt hours (kWh) and expected annual revenues of approximately 250 million Yuan, and expected annual net income (45% of Revenue) of approximately 112.5 million Yuan based on 8,000 annual operation hours. The electricity sale price is RMB 0.60 Yuan/kWh (approximately USD $0.080/kWh) with Government Policy Protection for the implement purchase electricity
'/>"/>

SOURCE China Holdings, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8
Related medicine news :

1. Chinas 1-child policy could backfire on its elderly
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
4. Bridgetech Announces Addition of the Agency for Healthcare Research and Quality as Content Provider in its Development of a Healthcare Web Portal in China
5. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
6. China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China
7. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
8. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
9. Supplier Assessments to Help Buyers Identify Reliable China Exporters
10. Study shows lead-based paint problem isnt isolated to China
11. Bracco Announces Initiative to Save Children in China at 2007 Annual Meeting of CGI

Post Your Comments:

(Date:11/27/2009)...., Nov. 27 GSI Group Inc...of precision technology products and semiconductor...f the Company,s shareholders has been scheduled fo...f the meeting will be announced in due course. As...isition notice from Stephen Bershad, a holder of g...

(Date:11/27/2009)...Biotech firm Replikins Ltd. today issued its lates...ata. It shows that the lethality of the virus has...e virus,s current outbreak in the spring of 2009 t...d. 0.1). The H1N1 infectivity count, however, rema...PRWEB) November 27, 2009 -- Biotech firm Replikins...

(Date:11/27/2009)...Nov. 27 The Gymboree Cor...bert, CFO/COO, will present at the NASDAQ OMX 23rd...air Hotel in London, England, on Wednesday, Decemb...a live broadcast of The Gymboree Corporation,s pre...gymboree.com, click on "Our Company" at the bottom...

(Date:11/27/2009)...SEINE, France, Nov. 27 Team Garmin...ng team dedicated to ethical sporting and developi...nced today that it will become Team Garmin-Transit... new sponsor of the team. Transitions Optical is t...r, offering the most advanced photochromic technol...

(Date:11/27/2009)...XenaCare Holdings has announced that it has become...ne of the largest nonprofit organizations dedicate...n. , Delray Beach, FL (Vo...(OTCBB: XCHO), a company specializing in the marke...e products, has announced today that is has become...

Breaking Medicine News(10 mins):Health News:GSI Group Calls Shareholders Meeting 2 Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2 Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3 Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4 Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5 Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2 Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3 Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2 Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3 Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4

[0] GSI Group Calls Shareholders Meeting [0] Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased [0] The Gymboree Corporation to Present at NASDAQ OMX 23rd Investor Program [0] Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor [0] XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation

...nd New Regulations Could Hold the Key to ...ORK, Nov. 8 It is estimated that more than 1,mill...the United States in,2007. While most skin cancers...e hopeful that the recent introduction,of a new la...

...e the Effects of Stress on the Skin, Hair and ... 8 Pending job cuts at the office.,Back-to-back f.... What do,they all have in common? In a word -- st...acne, brittle nails or even hair,loss. Speaking t...

... Universities to Develop a New Thrombectomy ... ST. PAUL, Minn., Nov. 8 In a unanimous decision ... support of Governor John Hoeven,and the state,s C...tate University (NDSU) to develop and manufacture ...

...Diabetes Day, November 14,is observed every year b...,and by others with an interest in diabetes. This ...and adolescents," provides an excellent opportunit...lth (NIH), researchers at more,than 150 medical ce...

...umatic Brain Injuries: The Signature,Wounds of Ope...m, WASHINGTON, Nov. 8 - Veterans for America,s,"T...identifies a number of,interrelated trends adverse...l traumas., This report is the result of VFA,s ag...

...harma, Inc.,(Nasdaq: IDMI ) today announced its f...nded September 30, 2007. Financial information pre...Pharma and its subsidiary, IDM,S.A. Cash and cash...any,s net cash outflow from operations and,investm...

Skin Cancer Prevention Update:Feeling Stressed?North Dakota Grants Enova Medical Technologies a $2.5 Million Centers of Excellence Grant World Diabetes Day Spotlights Type 1 Diabetes Increase and World Class Response Trends in Treatment of America's Wounded Warriors IDM Pharma Reports Third Quarter 2007 Financial Results

(Date:11/29/2009)...wire/ -- A large proportion of patients who underg...e unindicated and unnecessary additional image acq...exposure, according to a study presented today at ...North America (RSNA). ,, "It is the responsibil...tion to ensure that the dosage is as low as reason...

(Date:11/29/2009)...Newswire/ -- Royal Philips Electronics ( PHG, AEX:...need by showing its portfolio of products designed...al meeting of the Radiological Society of North Am...ps are several advancements and upgrades focused o...streamlining workflow to expand upon clinical capa...

(Date:11/29/2009)...ewswire/ -- FUJIFILM Medical Systems USA, Inc., th...FFDM) with over 7,000 installations, is pleased to...me in the US. The Aspire HD combines the use of a...generation detector technology and the smallest pi... resolution at a reduced dose for the patient. Th...

Breaking Medicine Technology:Unindicated CT Series Result in Unnecessary Radiation Exposure for Patients 2 Unindicated CT Series Result in Unnecessary Radiation Exposure for Patients 3 Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 2 Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 3 Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 4 Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 5 FUJIFILM's DR-based FFDM System Makes US Debut at RSNA 2 FUJIFILM's DR-based FFDM System Makes US Debut at RSNA 3 FUJIFILM's DR-based FFDM System Makes US Debut at RSNA 4 Intralase 26amp 3B 238220 3BBladeless 26amp 3B 238221 3B Lasik Gains Popularity in the Raleigh NC Area 49584 1 Intralase 26amp 3B 238220 3BBladeless 26amp 3B 238221 3B Lasik Gains Popularity in the Raleigh NC Area 49584 2 U S Army Increases Medical and Dental School Benefits 49582 1 U S Army Increases Medical and Dental School Benefits 49582 2 U S Army Increases Medical and Dental School Benefits 49582 3 BioMed Realty Trust Closes New 2418 Million Secured Loan 49580 1 BioMed Realty Trust Closes New 2418 Million Secured Loan 49580 2 BioMed Realty Trust Closes New 2418 Million Secured Loan 49580 3

[0] Unindicated CT Series Result in Unnecessary Radiation Exposure for Patients [0] Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients [0] FUJIFILM's DR-based FFDM System Makes US Debut at RSNA

...herapeutic Proteins at Tumor,Site, ARLINGTON HEIG...eons have delivered cancer fighting proteins throu...ith a 79 percent reduction,in tumor volume, accord...onstructive Surgery(R), the official medical journ...PS). This new delivery technique, which has,yet to...

...,AZN) today announced the submission of a suppleme...and Drug Administration (FDA) for SEROQUEL XR(TM),...seek approval for the,treatment of generalized anx...anxiety effect. It is the first time approval has ... in GAD. The submission is based on a robust,clini...

Other Medicine Technology:Skin Flaps Deliver Cancer-fighting Therapy, ASPS Study Reveals 2 Skin Flaps Deliver Cancer-fighting Therapy, ASPS Study Reveals 3 AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 2 AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 3 AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 4 AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 5 AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 6 AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 7 AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 8

Skin Flaps Deliver Cancer-fighting Therapy, ASPS Study Reveals AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines

...er is designed for fast & easy operation. The 5.7 ...for everyone., ,In AUTO mode, the readings are...ned. Multi-Focal lenses are automatically detected...rrectly position the lens. The color touch panel d...

Pro-lll

FF 450^plus Fundus Camera

TRC-50FXC

Medicine Products:

TL-3000B Auto Lensemeter Pro-lll FF 450^plus Fundus Camera TRC-50FXC

China Holdings, Inc. Announces 2nd Biomass Renewable Energy Project (Power Capacity: 50 MW); Total Potential: 100 MW in Biomass Energ...( LAS VEGAS Nov. 5 /Xinhua-- China ...),Health